The largest database of trusted experimental protocols

49 protocols using pflag cmv 2

1

Constructing Replicons and Reporter Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
The detailed construction of R1 replicon has been described previously (Su et al., 2020 (link)). Briefly, for R1 3DD330A, in which Asp330 was mutated to an Ala to disrupt the enzymatic activity, was constructed by PCR-based site-directed mutagenesis using the R1 replicon as a template (Su et al., 2020 (link)). The monocistronic reporter plasmid (IRES-Luc), which contains EV-A71 IRES at the 5′end and drives the translation of the luciferase protein, was described previously (Su et al., 2018 (link)). To construct pFlag-CMV2-HSPA6, HSPA6 gene was amplified from the cDNA of EV-A71 infected RD cells by nested PCR and then cloned into pFlag-CMV2 (Sigma-Aldrich) at NotI and KpnI sites to generate pFlag-HSPA6. A wobble HSPA6 mutation (nucleotides 7–9 GCC→GCA), which resists the action of sgRNA used in knockout cells, was generated by site-direct mutagenesis. HCV IRES-Luc was previously described (Su et al., 2018 (link)). CV-A16 IRES-Luc and Echo 9 IRES-Luc were gifts from Dr. Szu-Hao Kung (National Yang-Ming University, Taiwan) (Hou et al., 2016 (link)). EMCV IRES-Luc was generated by inserting firefly Luc gene into the pTM1 plasmid (Addgene).
+ Open protocol
+ Expand
2

Retroviral Expression of Dynein Adaptor Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full‐length cDNAs encoding dynAPa (NCBI accession number: NM_173629.1), dynAPb (NCBI accession number: NM_001307955.1), and dynAPc (NCBI accession number: XM_011525924.2) were subcloned into the pFLAG‐CMV2‐Bsd vector, a derivative of pFLAG‐CMV‐2 (Sigma‐Aldrich) carrying the blasticidin S deaminase gene, yielding plasmids expressing N‐terminally Flag‐tagged dynAPa–c. For retrovirus‐mediated expression, untagged dynAPa–c cDNAs were incorporated into the EcoRI and XhoI sites of the pMY‐IRES‐EGFP vector as described previously [9 (link)]. The resulting plasmids were introduced into Plat‐E cells using FuGENE 6 transfection reagent (Promega Co., Madison, WI, USA) according to the manufacturer's instructions. After 48 h, virus‐containing supernatants were filtered through 0.45 μm cellulose acetate filters and supplemented with 8 μg·mL−1 polybrene (Sigma‐Aldrich). NIH3T3 cells were then incubated overnight with the virus/polybrene‐containing supernatants. After infection, the medium was replaced with fresh medium. The expression, subcellular localization, and in vitro cell transformation ability were assessed in the resultant cells. Plasmids expressing N‐terminally Flag‐tagged dynAPa–c were transiently transfected into KMST‐6 cells using FuGENE HD (Promega), and subcellular localization of dynAPa–c was analyzed.
+ Open protocol
+ Expand
3

Plasmids for BKPyV agnoprotein expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The empty expression vector pRcCMV was purchased from Invitrogen (Invitrogen Life Technologies, Grand Island, NY, USA). The plasmid pRcCMV-agno which encodes BKPyV agnoprotein has been previously described [7 (link)]. Plasmid pFLAG-CMV-2 was obtained from Sigma Aldrich, while pFLAG-CMV-2 PCNA expression vector was a kind gift of Hong-Gang Wang [69 (link)]. pGST-agno has been described previously [34 (link)].
+ Open protocol
+ Expand
4

Molecular Mechanisms of HOXC13 Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
IMAGE clone 3600260 was used as the wild-type Spi1 expression construct and as the template for site-directed mutagenesis. IMAGE clone 6171228 was used as the wild-type HOXC13 expression vector. Primer sequences for Zfp521 promoter amplification listed in Supplemental Table 2. Promoter regions were cloned up stream of the luciferase gene in the pGL3 Basic plasmid. Nomenclature of the reporter plasmids is based on the approximate size of promoter regions. The human HOXC13 cDNA sequence was cloned in-frame into pFLAG-CMV2 (Sigma) to create the FLAG-tagged expression construct. The HOXC13 DNA-binding mutant construct (HOXC13-delta) was previously described (Potter et al., 2006 (link)).
+ Open protocol
+ Expand
5

Cloning and Characterization of SIGMAR1 Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole wild-type and mutant SIGMAR1-ORFs were distinctively amplified, with the use of appropriate restriction sites containing primers (online supplementary table S1), from cDNAs of a homozygous healthy individual and a patient with HMNJ, respectively and cloned into pEGFP-C3 (BD, California, USA) and pFLAG-CMV-2 (Sigma-Aldrich, Missouri, USA) vectors. With the employment of a Flag-tag containing forward primer and an appropriate reverse primer, Flag-tagged SIGMAR1 whole-ORFs were cloned from pFLAG-CMV-2 to the bicistronic vector pIRES2-EGFP (BD). All of the plasmid constructs were sequenced and verified to be free of any nucleotide changes in the SIGMAR1 cDNA.
+ Open protocol
+ Expand
6

ORF50 Promoter Characterization and Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pORF50p(−3801/+10)/luc reporter plasmid that contains the ORF50 promoter from −3801 to +10 was described previously (47 (link)). To construct ORF50 promoter deletion mutants shown in Fig. 3A, the indicated regions of the ORF50 gene promoter were amplified by PCR and cloned into pGL3-Basic (Promega). To further define the MLN4924 response elements, single or triple copies of specific transcription factor-binding motifs were cloned into pE4luc (49 (link)), a reporter plasmid containing a minimal adenovirus E4 promoter. The LANA expression vector was constructed by inserting a PCR-amplified LANA-coding gene fragment into pFLAG-CMV-2 (Sigma) at EcoRI and XbaI sites. The PCR primers used for amplification of the LANA-coding gene fragment were 5′-TTTGAATTCGATGGCGCCCCCGGGAATGCGCCT and 5′-AGGTCTAGAGGTGTGGCTTTTATGTCATTTCCT. The pCMV-HA-NEDD8 expression vector was obtained from OriGene (Rockville, MD).
+ Open protocol
+ Expand
7

Molecular tools for studying mRNA regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pre-miRNA, biotinylated miRs, inhibitor anti-miR, and control RNA oligomers were purchased from Exiqon. The myc-tagged mTOR (wild-type) and kinase dead mTOR mutant (mTOR-Kdm) expression constructs were purchased from Addgene (plasmids #1861 and #8482, respectively). All fluorescent reporter constructs for analyses of RNA translation were based on mCherry plasmid with myristoylation element (mChMYR; Vuppalanchi et al., 2012 (link)). Reporter constructs containing 5′ and 3′ UTRs of rat Nrn1, Gap43, and Kpnb1 mRNAs have been published (mChMYR5’/3’nrn1 or mChMYR5’/3’kpnb1, or mChMYR5’/3’gap43; Sahoo et al., 2018 (link)). For mTOR, the rat 3′ UTR was subcloned by PCR from previously published UTR constructs (Terenzio et al., 2018 (link)), and inserted directly downstream of the stop codon of mChMYR sequence in a vector that included 5′ UTR of rat CamkII mRNA (mChMYR5’camKII/3’mtor; Vuppalanchi et al., 2012 (link)). Rat PTEN protein coding sequence was generated from a rat DRG cDNA library. Using PCR primers with restriction enzyme sites (EcoRI and SalI), PTEN coding sequence was amplified with high fidelity polymerase (Primer Star HS, Takara) and inserted into pFLAG-CMV2 (Sigma) using EcoRI/SalI sites. All UTR reporter and cDNA expression constructs were confirmed by sequencing.
+ Open protocol
+ Expand
8

Overexpression of HOXA9 and Nanog in DLBCL

Check if the same lab product or an alternative is used in the 5 most similar protocols
HOXA9 cDNA was obtained by RT-PCR using primers as follows: forward, 5′- GAA TTC AAT GGC CAC CAC TGG GGC C-3′ and reverse, 5′- TCT AGA CTC GTC TTT TGC TCG GTC-3′. The products were subcloned into pFlag-CMV2 (Sigma-Aldrich, St. Louis, MO, USA) or pcDNA 3.1/myc-His A (Thermo Fisher Scientific, Waltham, MA, USA) by EcoRI and XbaI sites. Nanog-MycDDK was constructed in a pCMV6-Entry expression vector (Origene, Cat. No. RC210243, Rockville, MD, USA). Flag-HOXA9, HOXA9-MycHis, or Nanog-MycDDK was transfected into DLBCL cells (SU-DHL-5 or HT) by a transfection reagent (Lipofectamine 2000, Invitrogen, Grand Island, NY, USA) according to the manufacturer’s instructions. pFlag-CMV2, pcDNA 3.1/myc-His A, or pCMV6-Entry was transfected into cells as a vector control. The vectors are shown in Supplementary Fig. S2, S3.
+ Open protocol
+ Expand
9

POLR3B cDNA cloning and A1625G variant

Check if the same lab product or an alternative is used in the 5 most similar protocols
POLR3B cDNA was made from HeLa RNA using Superscript III First-strand synthesis system (ThermoFisher) and used to amplify the ORF starting at the 2nd codon. The PCR product was cloned in the BglII/BamHI sites of pFLAG-CMV2 (Sigma-Aldrich). The A1625G variant was introduced by site-directed mutagenesis using primers: 5’CCAAATGTTTCTTGTCTTTCTTAGTGGTAACATCTTAGGTGTCATTC and 5’GAATGACACCTAAGATGTTACCACTAAGAAAGACAAGAAACATTTGG. All constructs were verified by sequencing.
+ Open protocol
+ Expand
10

Constructing VZV Replication Protein Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression plasmids encoding VZV replication proteins were constructed by inserting individual coding regions from the genome of the VZV vOka vaccine strain (GenBank accession number: AB097932.1) into pFLAG-CMV-2 (no. E7398; Sigma-Aldrich) or into pEGFP-C2 (no. 6083–1; Clontech). The resultant plasmids were named pCMV-F-ORF6, pCMV-F-ORF16, pCMV-F-ORF28, pCMV-F-ORF29, pCMV-F-ORF51, pCMV-F-ORF52 and pCMV-F-ORF55, as well as pCMV-GFP-ORF6, pCMV-GFP-ORF16, pCMV-GFP-ORF28, pCMV-GFP-ORF29, pCMV-GFP-ORF51, pCMV-GFP-ORF52 and pCMV-GFP-ORF55. These constructed plasmids express full-length VZV replication proteins with an N-terminal FLAG tag or GFP tag. To generate the plasmids encoding deletion mutants of GFP-ORF16, the corresponding DNA fragments were amplified by PCR and then inserted into pEGFP-C2. The NLS-mutated construct of GFP-ORF16 was generated in pCMV-GFP-ORF16 using QuikChange site-directed mutagenesis kit (no. 200,524; Agilent Technologies). To construct the plasmids expressing F-(NLS)-ORF28 or F-ORF28-(NLS), a small DNA fragment encoding a functional NLS motif (amino acid residues: PKKKRKV) derived from the SV40 T antigen (Lanford and Butel, 1984 (link)) was inserted upstream or downstream of the ORF28 coding region in pCMV-F-ORF28.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!